Advertisement

Clinical Rheumatology

, Volume 29, Issue 8, pp 823–833 | Cite as

Behcet’s disease: from east to west

  • Fereydoun Davatchi
  • Farhad Shahram
  • Cheyda Chams-Davatchi
  • Hormoz Shams
  • Abdolhadi Nadji
  • Massoomeh Akhlaghi
  • Tahereh Faezi
  • Zahra Ghodsi
  • Alireza Faridar
  • Farima Ashofteh
  • Bahar Sadeghi Abdollahi
Review Article

Abstract

Behcet's disease (BD) is classified among vasculitides. There are actually five nationwide surveys of BD: Iran, Japan, China, Korea, and Germany. Among case series, four are on more than 200 cases (Turkey, Morocco, Tunisia, and UK). BD was classically seen around the Silk Route. Now, it is seen everywhere. The male to female ratios were, respectively (in nationwide surveys), 1.19, 0.98, 1.34, 0.63, and 1.40 to 1. The mean age at onset was 26.2, 35.7, 33.8, 29, and 26 years. Major manifestations were seen, respectively, in nationwide surveys: mucous membrane (oral aphthosis in 97%, 98%, 98%, 99%, and 98%; genital aphthosis in 65%, 73%, 76%, 83%, and 64%); skin manifestations (pseudo-folliculitis in 57%, N/A, 31%, N/A, and 62%; erythema nodosum in 22%, N/A, 38%, N/A, and 42%; ocular manifestations in 55%, 69%, 35%, 51%, and 53%). Minor manifestations were seen, respectively, in nationwide surveys: joint manifestations in 33%, 57%, 30%, 38%, and 53%; neurological manifestations in 9%, 11%, 6.5%, 4.6%, and 11%; gastrointestinal manifestations in 7%, 15.5%, 9%, 7.3%, and 12%; vascular involvement in 8.9%, 8.9%, 7.7%, 1.8%, and 13%; pulmonary manifestations in 0.3%, N/A, 2.2%, N/A, and 3.6%; cardiac manifestations in 0.5%, N/A, 4%, N/A, and 3.2%. Laboratory tests are not useful except the pathergy test, which was positive in 54%, 44%, N/A, 40%, and 34% of cases. ESR was normal in many patients. Diagnosis is based upon clinical manifestations. The International Criteria for Behcet's Disease (ICBD, 2006) may be of help, having a sensitivity of 98.2% and a specificity of 95.6% in Iranian patients.

Keywords

Behcet's disease 

Notes

Disclosure

None

References

  1. 1.
    Shahram F, Nadji A, Jamshidi AR et al (2004) Behcet's Disease in Iran, analysis of 5059 cases. Arch Iranian Med 7:9–14Google Scholar
  2. 2.
    Nakae K, Masaki F, Hashimoto T et al (1993) Recent epidemiological features of Behcet's Disease in Japan. In: Godeau P, Wechsler B (eds) Behcet's Disease. Elsevier Science Publishers B.V, Amsterdam, pp 145–151Google Scholar
  3. 3.
    Zhang Z, Peng J, Hou X, Dong Y (2006) Clinical manifestations of Behcet's Disease in Chinese patients. APLAR J Rheumatol 9:244–247CrossRefGoogle Scholar
  4. 4.
    Bang D, Lee JH, Lee ES et al (2001) Epidemiologic and clinical survey of Behcet's Disease in Korea: the first multicenter study. J Korean Med Sci 16:615–618PubMedGoogle Scholar
  5. 5.
    Altenburg A, Papoutsis N, Orawa H et al (2006) Epidemiologie und Klinik des Morbus Adamantiades-Behçet in Deutschland—Aktuelle pathogenetische Konzepte und therapeutische Möglichkeiten. J Dtsch Dermatol Ges 4:49–66CrossRefPubMedGoogle Scholar
  6. 6.
    Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet's Disease: an analysis of 2147 patients. Yonsei Med J 38:423–427PubMedGoogle Scholar
  7. 7.
    Benamour S, Naji T, Echchilali K et al (2006) Study of 1034 cases of Behcet's Disease. Clin Exp Rheumatol 24(suppl 42):S13Google Scholar
  8. 8.
    B'chir Hamzaoui S, Harmel A, Bouslam K et al (2006) Behcet's Disease in Tunisia. Clinical study of 519 cases. Rev Med Interne 27:742–750CrossRefPubMedGoogle Scholar
  9. 9.
    Seaman G, Pearce RA (1997) Behcet's Disease manifestation in a population drawn from the UK Behcet's Syndrome Society. In: Hamza M (ed) Behcet's Disease. Pub Adhoua, Tunisia, pp 196–199Google Scholar
  10. 10.
    Pande I, Uppal SS, Kailash S, Kumar A, Malaviya AN (1995) Behcet's Disease in India: a clinical, immunological, immunogenetic and outcome study. Br J Rheumatol 34:825–830CrossRefPubMedGoogle Scholar
  11. 11.
    al-Dalaan AN, al-Balaa SR, el Ramahi k, et al (1994) Behcet's Disease in Saudi Arabia. J Rheumatol 21:658–661Google Scholar
  12. 12.
    Sharquie Kh, Al-Araji A, Al-Rawi Z, Al-Yaqubi O, Hatem A (2000) Behcet's Disease in Iraqi patients. A prospective study from a newly established multidiscipline clinic. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 60–63Google Scholar
  13. 13.
    Madanat W, Fayyad F, Zureikat H et al (2000) Analysis of 150 patients with Behcet's Disease from Jordan. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 941–944Google Scholar
  14. 14.
    Ghayad E, Tohme A (1995) Behcet's Disease in Lebanon: report of 100 cases. J Med Libanais 43:2–7Google Scholar
  15. 15.
    Chajek T, Fainaru M (1975) Behcet's disease, report of 41 cases and a review of the literature. Medicine 54:179–196CrossRefPubMedGoogle Scholar
  16. 16.
    Assaad-Khalil SH, Kamel FA, Ismail EA (1997) Starting regional registry for patients with Behcet's Disease in North West Nile Delta region in Egypt. In: Hamza M (ed) Behcet's Disease. Pub Adhoua, Tunisia, pp 173–176Google Scholar
  17. 17.
    Berrah A, Remache A, Ouadahi N et al (2000) Clinical manifestations of Behcet's Disease. Analysis of 58 cases. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 77–82Google Scholar
  18. 18.
    Hamza M, Ayed K, Zribi A (1991) Maladie de Behçet. In: Kahn MF, Peltier AP, Meyer O, Piette JC (eds) Les Maladie Systémiques. Flammarion Médecine Sciences, Paris, pp 917–947Google Scholar
  19. 19.
    Shukurova SM (2000) Clinical aspects of Behcet's Disease in patients from Tadjikistan. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, p 83Google Scholar
  20. 20.
    Alekberova Z, Madanat W, Prokaeva T et al (1993) Clinical and genetic features of 35 patients with Behcet's disease from Commonwealth Independent States. In: Godeau P, Wechsler B (eds) Behcet's disease. Elsevier Science Publishers B.V, Amsterdam, pp 171–174Google Scholar
  21. 21.
    Kaklamani VG, Markomichelakis N, Vaiopoulos G et al (2000) Clinical features of Adamantiadis–Behcet's Disease in Greece. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 56–59Google Scholar
  22. 22.
    Valesini G, Pivetti Pezzi P, Catarinelli G et al (1991) Clinical manifestations of Behcet's disease in Italy: study of 155 patients at Rome University. In: O'Duffy JD, Kokmen E (eds) Behcet's Disease Basic and Clinical Aspects. Marcel Decker Inc, New York, pp 279–289Google Scholar
  23. 23.
    de Souza-Ramalho P, DAlmeida MF, Freitas JP, Pinto J (1991) Incidence and clinical aspects of Behcet's disease in Portugal. In: O'Duffy JD, Kokmen E (eds) Behcet's Disease Basic and Clinical Aspects. Marcel Decker Inc, New York, pp 291–298Google Scholar
  24. 24.
    Roux H, Richard P, Aarrighi A, Bergaoui N (1989) La maladie de Behçet autochtone. A propos de 73 cas. Rev Rhum 56:383–388PubMedGoogle Scholar
  25. 25.
    Calamia KT, Mazlumzadeh M, Balbanova M et al (2000) Clinical characteristics of United States patients with Behcet's Disease. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 48–51Google Scholar
  26. 26.
    Montenegro V, Carlotto De Abreu A, Schaimberg C, Roberto Gonçalves C (2000) Behcet's Disease in 81 Brazilian patients. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, p 945Google Scholar
  27. 27.
    Torras H, Lecha M, Mascaro JM, La talidomida en el tratamiento de las aftosis y enfermedad de Behcet (1982) Experiencia de cuatro anos. Med Cutan Ibero Lat Am 10:103–112PubMedGoogle Scholar
  28. 28.
    Davatchi F, Shahram F, Chams C et al (2005) Behcet's Disease. Acta Medica Iranica 43:233–242Google Scholar
  29. 29.
    Davatchi F, Jamshidi F, Tehrani Banihashemi A et al (2008) WHO-ILAR COPCORD Study (Stage 1, urban study) in Iran. J Rheumatol 35:1384–1390PubMedGoogle Scholar
  30. 30.
    Calamia KT, Wilson FC, Icen M et al (2009) Epidemiology and clinical characteristics of Behçet's Disease in the US: a population-based study. Arthritis Rheum 61:600–604CrossRefPubMedGoogle Scholar
  31. 31.
    Mahr A, Belarbi L, Wechsler B et al (2008) Population-based prevalence study of Behcet's Disease. Differences by ethnic origin and variation by age at immigration. Arthritis Rheum 58:3951–3959CrossRefPubMedGoogle Scholar
  32. 32.
    Chamberlain MA (1977) Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis 36:491–499CrossRefPubMedGoogle Scholar
  33. 33.
    Chams-Davatchi C, Davatchi F, Shahram F et al (1998) Les aspect réels, typiques et atypiques, des lésions cutanées et muqueuses de la maladie de Behçet. A propos de 3751 cas. Ann Dermatol Venereol 125:3S153–3S154Google Scholar
  34. 34.
    Benamour S, Zeroual B, Alaoui FZ (1998) Joint manifestations in Behcet's Disease. A review of 340 cases. Rev Rhum 65:299–307Google Scholar
  35. 35.
    Abou-Seif M, Assaad-Khalil S, El-Siwy F, El-Sawy M (1993) Prevalence of ankylosing spondylitis and sacroiliitis in 250 patients with Behcet's Disease: clinical, radiological, and genetic study. In: Godeau P, Wechsler B (eds) Behcet's Disease. Elsevier Science Publishers B.V, Amsterdam, pp 285–289Google Scholar
  36. 36.
    Al-Rawi ZS, Sharqui KE, Al-Hadithi FM, Munir JJ (1986) Behcet's disease in Iraqi patients. Ann Rheum Dis 45:987–990CrossRefPubMedGoogle Scholar
  37. 37.
    Sikaroodi H, Soroosh S, Shahram F et al (1992) Neurological manifestations of Behcet's Disease. Analysis of 1772 cases. In: Nasution AR, Darmawan J, Isbagio H (eds) Rheumatology APLAR 1992. Churchill Livingstone, Tokyo, pp 107–109Google Scholar
  38. 38.
    Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical pattern of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122:2171–2182CrossRefPubMedGoogle Scholar
  39. 39.
    Lee CR, Kim WH, Cho YS et al (2000) Differentiation of intestinal Behcet's Disease and Crohn's disease by colonoscopic findings. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, p 384Google Scholar
  40. 40.
    Assaad-Khalil SH, Rafla SM, Yacout YM et al (2000) Prevalence of cardiovascular involvement in patients with Behcet's Disease using angiography, color duplex sonography, Doppler echocardiography and CATS. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 791–799Google Scholar
  41. 41.
    Morelli S, Perrone C, Ferrante L et al (1997) Cardiac involvement in Behcet's Disease. Cardiology 88:513–517CrossRefPubMedGoogle Scholar
  42. 42.
    Shahram F, Eslami M, Shakoori B et al (2000) Cardiac involvement in Behcet's Disease, a case control study. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 810–814Google Scholar
  43. 43.
    Davatchi F, Chams-Davatchi C, Shahram F et al (2007) Pathergy test in Behcet's Disease: change in incidence over the time. APLAR J Rheumatol 10:333–335CrossRefGoogle Scholar
  44. 44.
    Davatchi F, Shahram F, Nadji A et al (2006) Performance of existing diagnosis/classification criteria for Behcet's Disease in Iranian patients: analysis of 5666 patients and 2406 controls. APLAR J Rheumatol 9:238–243CrossRefGoogle Scholar
  45. 45.
    Davatchi F, Shahram F, Akbarian M et al (1993) Classification Tree for the diagnosis of Behcet's Disease. In: Godeau P, Wechsler B (eds) Behcet's Disease. Elsevier Science Publishers B.V, Amsterdam, pp 245–248Google Scholar
  46. 46.
    APLAR subcommittee for Behcet's Disease (1998) APLAR evaluation of Behcet's Disease diagnosis criteria. APLAR J Rheumatol 1:237–240Google Scholar
  47. 47.
    International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD) (2006) Evaluation of the International Criteria for Behcet's Disease (ICBD). Clin Exp Rheumatol 24(suppl 42):S13Google Scholar
  48. 48.
    International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD) (2006) Revision of the International Criteria for Behcet's Disease (ICBD). Clin Exp Rheumatol 24(suppl 42):S14–S15Google Scholar
  49. 49.
    Davatchi F, Sadeghi Abdollahi B, Shahram F et al (2010) Validation of the International Criteria for Behcet's Disease (ICBD) in Iran. Int J Rheum Dis 13: (In Press)Google Scholar
  50. 50.
    Davatchi F, Shahram F, Chams C et al (2000) Epidemiology of Behcet's Disease in Iran. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 589–591Google Scholar
  51. 51.
    Shahram F, Chams C, Davatchi F et al (2000) Familial study in Behcet's Disease, analysis of 1242 patients. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 605–608Google Scholar
  52. 52.
    Mizuki N, Inoko H, Sugimura K et al (1992) Human leucocyte antigen serologic and DNA typing of Behcet's Disease and its primary association with HLA-B51. Invest Ophthalmol Vis Sci 33:3332–3340PubMedGoogle Scholar
  53. 53.
    Balboni A, Pivetti-Pezzi P, Orlando P et al (1992) Serological and molecular HLA typing in Italian Behcet's patients: significant association to B-51-DR5-DQw3 haplotype. Tissue Antigens 39:141–143CrossRefPubMedGoogle Scholar
  54. 54.
    Mizuki N, Nakamura S, Ando H, Inoko H, Ohno S (1993) Molecular genetic studies on Behcet's Disease: in Behcet's Disease. In: Godeau P, Wechsler B (eds) Behcet's Disease. Elsevier Science Publishers B.V, Amsterdam, pp 33–36Google Scholar
  55. 55.
    Hayasaka S, Kurome H, Noda S (1994) HLA antigens in a Japanese family with Behcet's Disease. Graefe Arch Clin Exp Ophthalmol 232:582–590CrossRefGoogle Scholar
  56. 56.
    Mizuki N, Ohno S, Ando H et al (1996) HLA-C genotyping of patients with Behcet's Disease in the Japanese population. Hum Immunol 50:47–53CrossRefPubMedGoogle Scholar
  57. 57.
    Mizuki N, Ota M, Kimura M et al (1997) Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet's Disease. Proc Natl Acad Sci USA 94:1298–1303CrossRefPubMedGoogle Scholar
  58. 58.
    Mizuki N, Ota M, Yabuki K et al (2000) Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 41:3702–3708PubMedGoogle Scholar
  59. 59.
    de Menthon M, LaValley M, Maldini C, Guillemin L, Mahr A (2009) HLA-B51/B5 and the risk of Behcet's Disease: a systematic review and meta-analysis of case–control genetic association studies. Arthritis Rheum 61:1287–1296CrossRefPubMedGoogle Scholar
  60. 60.
    Davatchi F, Shahram F, Nadji A et al (2008) HLA-B51 in Behcet's Disease. Acta Med Iran 46:507–510Google Scholar
  61. 61.
    Davatchi F, Shahram F, Chams-Davatchi C et al (2010) How to deal with Behcet's Disease in the daily practice. Int J Rheumatic Dis 13: (In Press)Google Scholar

Copyright information

© Clinical Rheumatology 2010

Authors and Affiliations

  • Fereydoun Davatchi
    • 1
  • Farhad Shahram
    • 1
  • Cheyda Chams-Davatchi
    • 1
  • Hormoz Shams
    • 1
  • Abdolhadi Nadji
    • 1
  • Massoomeh Akhlaghi
    • 1
  • Tahereh Faezi
    • 1
  • Zahra Ghodsi
    • 1
  • Alireza Faridar
    • 1
  • Farima Ashofteh
    • 1
  • Bahar Sadeghi Abdollahi
    • 1
  1. 1.Behcet’s Disease Unit, Rheumatology Research Center, Shariati HospitalMedical Sciences/University of TehranTehranIran

Personalised recommendations